BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31038395)

  • 1. Tumor-suppressive activity of Hnf1β in Wilms' tumor.
    Liu Y; Kanyomse Q; Xie Y
    Biosci Biotechnol Biochem; 2019 Nov; 83(11):2008-2015. PubMed ID: 31038395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
    Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis
    Zhou N; Yan B; Ma J; Jiang H; Li L; Tang H; Ji F; Yao Z
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney.
    Garvin AJ; Re GG; Tarnowski BI; Hazen-Martin DJ; Sens DA
    Am J Pathol; 1993 Feb; 142(2):375-80. PubMed ID: 8382007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
    Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
    Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-27a-5p Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis of Wilms' Tumor Cell by Targeting PBOV1.
    Guo ZT; Yu Q; Miao C; Ge W; Li P
    Mol Cell Biol; 2022 Aug; 42(8):e0039721. PubMed ID: 35862727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.
    Zhu KR; Sun QF; Zhang YQ
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00667 promotes Wilms' tumor metastasis and stemness by sponging miR-200b/c/429 family to regulate IKK-β.
    Liu P; Chen S; Huang Y; Xu S; Song H; Zhang W; Sun N
    Cell Biol Int; 2020 Jun; 44(6):1382-1393. PubMed ID: 32129525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG6 Promotes Wilms' Tumor Progression Through Regulating miR-429/FRS2 Axis.
    Wang Y; Liu J; Yao Q; Wang Y; Liu Z; Zhang L
    Cancer Biother Radiopharm; 2024 May; 39(4):264-275. PubMed ID: 33481659
    [No Abstract]   [Full Text] [Related]  

  • 12. Up-regulation of miR-190b promoted growth, invasion, migration and inhibited apoptosis of Wilms' tumor cells by repressing the PTEN expression.
    An NN; Shawn J; Peng JP; Wu MD; Huang LG
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):961-969. PubMed ID: 29509256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localization of HGF and met in Wilms' tumours.
    Alami J; Williams BR; Yeger H
    J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CITED1 expression in Wilms' tumor and embryonic kidney.
    Lovvorn HN; Westrup J; Opperman S; Boyle S; Shi G; Anderson J; Perlman EJ; Perantoni AO; Wills M; de Caestecker M
    Neoplasia; 2007 Jul; 9(7):589-600. PubMed ID: 17710162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMX2OS Delays Wilms'Tumor Progression via Targeting miR-654-3p.
    Chen ZH; Cui MY; Zhang HM
    Ann Clin Lab Sci; 2022 Jan; 52(1):12-20. PubMed ID: 35181613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.
    Natrajan R; Little SE; Reis-Filho JS; Hing L; Messahel B; Grundy PE; Dome JS; Schneider T; Vujanic GM; Pritchard-Jones K; Jones C
    Clin Cancer Res; 2006 Dec; 12(24):7284-93. PubMed ID: 17189400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
    Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
    Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LINC01339 Hinders the Development of Wilms' Tumor via MiR-135b-3p/ADH1C Axis.
    Yu Y; Liu Y
    Horm Metab Res; 2024 Mar; 56(3):244-254. PubMed ID: 37890508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine inhibits Wilms' tumor cell progression through upregulation of Wilms' tumor gene on the X chromosome.
    Liu Y; Liu S
    Mol Med Rep; 2013 Nov; 8(5):1537-41. PubMed ID: 24002362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.